Ileus News and Research

RSS
Ileus or gastrointestinal atony is a disruption of the normal propulsive gastrointestinal motor activity due to non-mechanical causes.
New disposable device may help doctors to monitor post-operative ileus

New disposable device may help doctors to monitor post-operative ileus

Trevena's Phase 1b data for TRV130 published in the journal Pain

Trevena's Phase 1b data for TRV130 published in the journal Pain

Bristol-Myers Squibb to present new immunotherapy study data at ASCO Annual Meeting

Bristol-Myers Squibb to present new immunotherapy study data at ASCO Annual Meeting

Report describes cardiopulmonary arrest in infant following cyclopentolate eyedrops

Report describes cardiopulmonary arrest in infant following cyclopentolate eyedrops

Unexpected toxicity of pazopanib/pemetrexed in NSCLC halts study

Unexpected toxicity of pazopanib/pemetrexed in NSCLC halts study

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

New recovery program for abdominal surgery patients improves recovery process

New recovery program for abdominal surgery patients improves recovery process

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Cubist seeks FDA sNDA approval for ENTEREG to accelerate GI recovery

Cubist seeks FDA sNDA approval for ENTEREG to accelerate GI recovery

NICE decides to recommend Bristol-Myers Squibb’s YERVOY for treatment of advanced melanoma

NICE decides to recommend Bristol-Myers Squibb’s YERVOY for treatment of advanced melanoma

ProStrakan acquires US commercial rights to Fareston for treatment of metastatic breast cancer

ProStrakan acquires US commercial rights to Fareston for treatment of metastatic breast cancer

Merz acquires CUVPOSA oral solution to treat children with cerebral palsy

Merz acquires CUVPOSA oral solution to treat children with cerebral palsy

Mallinckrodt receives FDA approval for 32 mg tablet strength of EXALGO

Mallinckrodt receives FDA approval for 32 mg tablet strength of EXALGO

Data from Purdue Pharma’s Butrans clinical trials to be presented at APS annual meeting

Data from Purdue Pharma’s Butrans clinical trials to be presented at APS annual meeting

Janssen’s NUCYNTA ER tablets more effective in providing pain management in adults with DPN

Janssen’s NUCYNTA ER tablets more effective in providing pain management in adults with DPN

Researchers identify gene that increases risk of MI in newborns with CF

Researchers identify gene that increases risk of MI in newborns with CF

Researchers discover multiple genes associated with meconium ileus

Researchers discover multiple genes associated with meconium ileus

Genetic variations could be linked with meconium ileus in CF patients

Genetic variations could be linked with meconium ileus in CF patients

Shire, Janssen enter development and marketing agreement for Resolor

Shire, Janssen enter development and marketing agreement for Resolor

Shire acquires rights to develop and market Resolor in the U.S.

Shire acquires rights to develop and market Resolor in the U.S.